BIAFW (STOCKS)
bioAffinity Technologies, Inc. Warrant
$0.070000
-0.004700 (-6.29%)
Prev close: $0.074700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Maria Zannes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 57
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.90M |
| Benefits Costs and Expenses | $21.08M |
| Costs And Expenses | $21.08M |
| Nonoperating Income/Loss | -$2.80M |
| Operating Expenses | $18.28M |
| Selling, General, and Administrative Expenses | $11.35M |
| Depreciation and Amortization | $413.09K |
| Research and Development | $1.42M |
| Other Operating Expenses | $5.11M |
| Operating Income/Loss | -$12.38M |
| Income/Loss From Continuing Operations After Tax | -$15.19M |
| Income/Loss From Continuing Operations Before Tax | -$15.18M |
| Net Income/Loss | -$15.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$15.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.30 |
| Diluted Earnings Per Share | -$7.30 |
| Basic Average Shares | 11,704,333 |
| Diluted Average Shares | 11,704,333 |
| Assets | $7.62M |
| Current Assets | $3.87M |
| Inventory | $82.38K |
| Other Current Assets | $3.78M |
| Noncurrent Assets | $3.75M |
| Fixed Assets | $313.71K |
| Intangible Assets | $687.64K |
| Other Non-current Assets | $2.75M |
| Liabilities | $3.85M |
| Current Liabilities | $2.68M |
| Accounts Payable | $969.85K |
| Wages | $869.29K |
| Other Current Liabilities | $841.77K |
| Noncurrent Liabilities | $1.17M |
| Equity | $3.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.77M |
| Liabilities And Equity | $7.62M |
| Net Cash Flow From Operating Activities | -$11.47M |
| Net Cash Flow From Operating Activities, Continuing | -$11.47M |
| Net Cash Flow From Investing Activities | -$91.99K |
| Net Cash Flow From Investing Activities, Continuing | -$91.99K |
| Net Cash Flow From Financing Activities | $13.19M |
| Net Cash Flow From Financing Activities, Continuing | $13.19M |
| Net Cash Flow | $1.63M |
| Net Cash Flow, Continuing | $1.63M |
| Comprehensive Income/Loss | -$15.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.19M |
| Other Comprehensive Income/Loss | $0.00 |